SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGEN, SPPI, HOTH

NEW YORK, April 27, 2023

Seagen Inc. (NASDAQ: SGEN)'s sale to Pfizer Inc. for $229.00 in cash per share. If you are a Seagen shareholder, click here to learn more about your rights and options.  

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)'s sale to Assertio Holdings, Inc. Under the terms of the agreement, Spectrum shareholders will receive: (1) 0.1783 shares of Assertio common stock for each share of Spectrum common stock they own; and (2) one contingent value right per Spectrum share for the right to receive $0.10 payable upon ROLVEDON net sales (less certain deductions) achieving $175 million during the calendar year ending December 31, 2024, and $0.10 payable upon ROLVEDON net sales (less certain deductions) achieving $225 million during the calendar year ending December 31, 2025. If you are a Spectrum shareholder, click here to learn more about your rights and options.  

Hoth Therapeutics, Inc. (NASDAQ: HOTH)'s merger with Algorithm Sciences, Inc. Upon completion of the proposed transaction, Hoth shareholders are expected to own approximately 14% of the combined company. If you are a Hoth shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.